Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Developmental changes of caffeine elimination in infancy.

G Pons1, O Carrier, M O Richard

  • 1Département de Pharmacologie Périnatale et Pédiatrique, Hôpital Saint-Vincent de Paul, Université René Descartes, Paris, France.

Developmental Pharmacology and Therapeutics
|January 1, 1988
PubMed
Summary

Caffeine citrate dosing for apnea in neonates and infants requires careful adjustment based on age. Monitoring plasma concentrations is essential to ensure safe and effective treatment, with recommended intervals varying by postnatal age.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Caregiving style and quality of life in caregivers of patients with cardiovascular disease.

Psychology & health·2025
Same author

A qualitative exploration of cAregiver experienCes Of conseRvatively maNaged kidney failure: the ACORN study.

BMC nephrology·2025
Same author

Effectiveness of interventions for informal caregivers of people with end-stage chronic illness: a systematic review.

Systematic reviews·2024
Same author

Treatment of Obesity with Thyroid hormones in Europe. Data from the THESIS* Collaboration.

Journal of endocrinological investigation·2024
Same author

Cerebral Phospho-Tau Acts Synergistically with Soluble Aβ42 Leading to Mild Cognitive Impairment in AAV-AD Rats.

The journal of prevention of Alzheimer's disease·2022
Same author

Management of anticoagulation in pregnant women with venous thromboembolism: An international survey of clinical practice.

Thrombosis research·2021

Area of Science:

  • Neonatal pharmacology
  • Pediatric pharmacokinetics

Background:

  • Apnea is a common respiratory issue in neonates and infants.
  • Caffeine citrate is frequently used to manage apnea in this population.
  • Individual variability in drug metabolism necessitates tailored dosing strategies.

Purpose of the Study:

  • To establish age-dependent dosing guidelines for caffeine citrate in neonates and infants.
  • To determine optimal dosing intervals to maintain therapeutic caffeine plasma concentrations.
  • To emphasize the importance of therapeutic drug monitoring for caffeine therapy.

Main Methods:

  • Plasma samples were collected at various time points after dosing in neonates and infants.
  • Caffeine plasma concentrations were quantified using High-Performance Liquid Chromatography (HPLC).

Related Experiment Videos

  • Pharmacokinetic parameters (half-life, clearance) were analyzed in relation to gestational and postnatal age.

    • Main Results:

    • Caffeine elimination half-life and clearance showed significant correlations with gestational and postnatal age.
    • A plateau in caffeine metabolism was observed around the second trimester of postnatal life.
    • Age-specific dosing intervals (24, 12, 8, and 6 hours) and doses (2-10 mg/kg) were proposed.

    Conclusions:

    • Age-dependent pharmacokinetic variability significantly impacts caffeine citrate dosing in neonates and infants.
    • The derived dosing regimen aims to maintain therapeutic caffeine plasma levels (7.5-14.5 mg/l).
    • Mandatory monitoring of caffeine plasma concentrations is crucial for safe and effective treatment in infants.